α-Synuclein molecular behavior and nigral proteomic profiling distinguish subtypes of Lewy body disorders.

Autor: Martinez-Valbuena, Ivan, Swinkin, Emily, Santamaria, Enrique, Fernandez-Irigoyen, Joaquin, Sackmann, Valerie, Kim, Ain, Li, Jun, Gonzalez-Latapi, Paulina, Kuhlman, Greg, Bhowmick, Suvorit Subhas, Visanji, Naomi P., Lang, Anthony E., Kovacs, Gabor G.
Předmět:
Zdroj: Acta Neuropathologica; Aug2022, Vol. 144 Issue 2, p167-185, 19p
Abstrakt: Lewy body disorders (LBD), characterized by the deposition of misfolded α-synuclein (α-Syn), are clinically heterogeneous. Although the distribution of α-Syn correlates with the predominant clinical features, the burden of pathology does not fully explain the observed variability in clinical presentation and rate of disease progression. We hypothesized that this heterogeneity might reflect α-Syn molecular diversity, between both patients and different brain regions. Using an ultra-sensitive assay, we evaluated α-Syn seeding in 8 brain regions from 30 LBD patients with different clinical phenotypes and disease durations. Comparing seeding across the clinical phenotypes revealed that hippocampal α-Syn from patients with a cognitive-predominant phenotype had significantly higher seeding capacity than that derived from patients with a motor-predominant phenotype, whose nigral-derived α-Syn in turn had higher seeding capacity than that from cognitive-predominant patients. Interestingly, α-Syn from patients with rapid disease progression (< 3 years to development of advanced disease) had the highest nigral seeding capacity of all the patients included. To validate these findings and explore factors underlying seeding heterogeneity, we performed in vitro toxicity assays, and detailed neuropathological and biochemical examinations. Furthermore, and for the first time, we performed a proteomic-wide profiling of the substantia nigra from 5 high seeder and 5 low seeder patients. The proteomic data suggests a significant disruption in mitochondrial function and lipid metabolism in high seeder cases compared to the low seeders. These observations suggest that distinct molecular populations of α-Syn may contribute to heterogeneity in phenotypes and progression rates in LBD and imply that effective therapeutic strategies might need to be directed at an ensemble of differently misfolded α-Syn species, with the relative contribution of their differing impacts accounting for heterogeneity in the neurodegenerative process. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index